WHO Recommends Dolutegravir as Preferred HIV Treatment Option in All Populations
23 Jul, 2019 | 02:03h | UTC
Related Commentary on Twitter
WHO recommends the use of the #HIV drug #dolutegravir as the preferred first-line and second-line treatment for all populations, including pregnant women and those of childbearing potential, based on new evidence from two large clinical trials in Africa https://t.co/owoDyXIMeZ pic.twitter.com/9qjpMnKgcY
— World Health Organization (WHO) (@WHO) July 22, 2019